Recent news, insights, research and analysis
About ICG
We are a global alternative asset manager with a 35-year track record, creating sustainable value by partnering with ambitious businesses. Today we manage $98.4bn across:
Corporate strategies | Real Assets strategies | Credit strategies
ICG insights
ICG insights
Recent news, insights, research and analysis
Grey Wolf Therapeutics closes oversubscribed $50 million Series B financing expansion
Led by ICG Life Sciences team, to accelerate and expand first-of-its-kind antigen modulation technology
Funding development in today’s market
Development viability has changed, but that may be good news for debt investors, says ICG Real Estate’s Jai Patel
Final results for the financial year ended 31 March 2024
Delivering multiple levers of growth
ICG Invests in Astek, Leading Player in Consulting Services
“We are convinced that Astek is best placed to benefit from the structural growth of the digital transformation markets, led by a high calibre management team and we look forward to helping Jean-Luc and Julien deliver their vision.”
The ICG platform
The breadth of our firm underpins our ability to invest across the capital structure and create value through cycles. Explore our flexible investment strategies and financing solutions.
Get in touch
To find out more about our flexible and sustainable solutions for both providers and users of capital, please contact us.
Contact Us![](https://www.icgam.com/wp-content/uploads/2023/11/ICG_2023_10_NYC_Photoshoot_01092-Edit-600x600.jpg)